Akoya Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
For the full year, revenue was USD 96.63 million compared to USD 74.86 million a year ago. Net loss was USD 63.32 million compared to USD 70.64 million a year ago. Basic loss per share from continuing operations was USD 1.43 compared to USD 1.87 a year ago. Diluted loss per share from continuing operations was USD 1.43 compared to USD 1.87 a year ago.